fda glp-1 warning september 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of fda warning letters compounding semaglutide

Patients needing more aggressive weight reduction (20%+ body weight loss) are likely better served by tirzepatide or future triple-agonist therapies like retatrutide that produce higher average weight loss

How to choose a product Pick a product that states the exact form and dose per serving

Here, some info to know: Berberine works by activating an enzyme called AMPK (activated protein kinase), which helps manage metabolism, according to lab and animal studies

The dose of one dropper is 5 ml and is specifically designed to burn and eliminate stubborn fat from the body, especially effective in reducing visceral and abdominal fat

In February 2025, the FDA declared the semaglutide shortage resolved